Table 4. Multivariate analysis of hemorrhagic transformation (HT) and prognosis in patients with elevated or normal hs-cTnT levels.^*.

	P	OR	95%CI
HT	0.010	4.021	1.391–11.625
Prognosis
Death
3 mos.	0.042	5.498	1.062–28.448
6 mos.	0.292	2.058	0.630–6.727
12 mos.	0.311	1.806	0.578–5.639
Disability
3 mos.	0.700	0.815	0.287–2.313
6 mos.	0.901	0.926	0.272–3.147
12 mos.	0.961	1.035	0.257–4.172
Death/disability
3 mos.	0.154	2.230	0.740–6.720
6 mos.	0.466	1.691	0.412–6.940
12 mos.	0.380	2.080	0.405–10.676

*Data were adjusted for age, sex, hypertension, renal impairment and NIHSS score on admission.